Literature DB >> 23333021

Target delineation in stereotactic body radiation therapy for recurrent head and neck cancer: a retrospective analysis of the impact of margins and automated PET-CT segmentation.

Kyle Wang1, Dwight E Heron, David A Clump, John C Flickinger, Gregory J Kubicek, Jean-Claude M Rwigema, Robert L Ferris, James P Ohr, Annette E Quinn, Cihat Ozhasoglu, Barton F Branstetter.   

Abstract

BACKGROUND: Few guidelines exist on stereotactic body radiation therapy (SBRT) treatment planning for recurrent head and neck cancer. We assessed the impact of retrospectively adding margins/automated PET volumes to the gross tumor volume (GTV) in patients with post-SBRT recurrences.
MATERIALS AND METHODS: We reviewed 89 patients with recurrent head and neck cancer treated with SBRT using no margin around the GTV. GTVs were recontoured with 1-5mm margins. PET-CT planned GTVs were also recontoured by adding PET-standardized uptake value (SUV)(3.5), SUV(4.5), SUV(40% max), and signal/background ratio (SBR) to the original GTV. We deformably registered recontoured GTVs to post-SBRT scans and assessed fraction of recurrence volume (RV) falling within the GTV, the "RV-GTV overlap."
RESULTS: With non-PET-CT planning, median RV-GTV overlap increased from 11.7% to 48.2% using 5mm margins, and median GTV size increased by 41.8 cc (156%). With PET-CT planning, RV-GTV overlap increased from 45% to 93.6% using 5mm margins, and GTV size increased by 34.8 cc (140%). Adding SUV(3.5) and SBR increased RV-GTV overlap from 45% to 73.3% and 73.6%, with GTV size increases of 0.8 (3%) and 3.1 cc (11%), respectively.
CONCLUSIONS: Recontouring increased recurrence coverage and also GTV size. Margins up to 5mm may reduce failures but could possibly increase toxicities. Automated PET contours may reduce near-miss failures with smaller increases in GTV size.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23333021     DOI: 10.1016/j.radonc.2012.11.008

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

1.  Stereotactic body radiotherapy for recurrent oropharyngeal cancer - influence of HPV status and smoking history.

Authors:  Kara S Davis; John A Vargo; Robert L Ferris; Steven A Burton; James P Ohr; David A Clump; Dwight E Heron
Journal:  Oral Oncol       Date:  2014-08-28       Impact factor: 5.337

2.  Comparison of Intrafractional Motion in Head and Neck Cancer Between Two Immobilization Methods During Stereotactic Ablative Radiation Therapy by CyberKnife.

Authors:  Chen-Lin Kang; Tsair-Fwu Lee; Shan-Ho Chan; Shyh-Chang Liu; Jui-Chu Wang; Cheng-Hsiang Tsai; Kuan-Cho Liao; Fu-Min Fang; Liyun Chang; Chun-Chieh Huang
Journal:  Cancer Manag Res       Date:  2021-01-05       Impact factor: 3.989

3.  Stereotactic body radiotherapy as primary treatment for elderly patients with medically inoperable head and neck cancer.

Authors:  John A Vargo; Robert L Ferris; David A Clump; Dwight E Heron
Journal:  Front Oncol       Date:  2014-08-11       Impact factor: 6.244

Review 4.  Advances in Image-Guided Radiotherapy in the Treatment of Oral Cavity Cancer.

Authors:  Hsin-Hua Nien; Li-Ying Wang; Li-Jen Liao; Ping-Yi Lin; Chia-Yun Wu; Pei-Wei Shueng; Chen-Shuan Chung; Wu-Chia Lo; Shih-Chiang Lin; Chen-Hsi Hsieh
Journal:  Cancers (Basel)       Date:  2022-09-23       Impact factor: 6.575

5.  Adaptive threshold segmentation of pituitary adenomas from FDG PET images for radiosurgery.

Authors:  Hannah M Thomas T; Devakumar Devadhas; Danie K Heck; Ari G Chacko; Grace Rebekah; Regi Oommen; E James J Samuel
Journal:  J Appl Clin Med Phys       Date:  2014-11-08       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.